NOOR, M.H. et al. 2025. Open-Label Randomized Trial of High-Dose Rifampicin to Shorten Treatment for Drug-Sensitive Pulmonary TB (Hi-Dori-3). Annals of Pakistan Medical & Allied Professionals. 1, 7, October (Oct. 2025), 7–11. DOI:https://doi.org/10.53350/Annalspakmed.1.7.7.